{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:33:49Z","timestamp":1777451629001,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100003851","name":"Hermansky-Pudlak Syndrome Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hermansky-Pudlak syndrome (HPS) is an autosomal recessive disorder characterized by improper biogenesis of lysosome-related organelles (LROs). Lung fibrosis is the leading cause of death among adults with HPS-1 and HPS-4 genetic types, which are associated with defects in the biogenesis of lysosome-related organelles complex-3 (BLOC-3), a guanine exchange factor (GEF) for a small GTPase, Rab32. LROs are not ubiquitously present in all cell types, and specific cells utilize LROs to accomplish dedicated functions. Fibroblasts are not known to contain LROs, and the function of BLOC-3 in fibroblasts is unclear. Here, we report that lung fibroblasts isolated from patients with HPS-1 have increased migration capacity. Silencing HPS-1 in normal lung fibroblasts similarly leads to increased migration. We also show that the increased migration is driven by elevated levels of Myosin IIB. Silencing <jats:italic>HPS1<\/jats:italic> or <jats:italic>RAB32<\/jats:italic> in normal lung fibroblasts leads to increased MYOSIN IIB levels. MYOSIN IIB is downstream of p38-MAPK, which is a known target of angiotensin receptor signaling. Treatment with losartan, an angiotensin receptor inhibitor, decreases MYOSIN IIB levels and impedes HPS lung fibroblast migration in vitro. Furthermore, pharmacologic inhibition of angiotensin receptor with losartan seemed to decrease migration of HPS lung fibroblasts in vivo in a zebrafish xenotransplantation model. Taken together, we demonstrate that BLOC-3 plays an important role in MYOSIN IIB regulation within lung fibroblasts and contributes to fibroblast migration.<\/jats:p>","DOI":"10.1186\/s12931-022-02083-w","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T12:15:04Z","timestamp":1655986504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dysregulated myosin in Hermansky-Pudlak syndrome lung fibroblasts is associated with increased cell motility"],"prefix":"10.1186","volume":"23","author":[{"given":"Jewel","family":"Imani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven P. M.","family":"Bodine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony M.","family":"Lamattina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane D.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikshya","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn M.","family":"Maynard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arinze","family":"Nwokeji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May Christine V.","family":"Malicdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren C.","family":"Testa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raman","family":"Sood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Stump","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan O.","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Perrella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Handin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa R.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette R.","family":"Gochuico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souheil","family":"El-Chemaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"issue":"15","key":"2083_CR1","doi-asserted-by":"publisher","first-page":"8770","DOI":"10.1073\/pnas.1532040100","volume":"100","author":"R Nazarian","year":"2003","unstructured":"Nazarian R, Falcon-Perez JM, Dell\u2019Angelica EC. Biogenesis of lysosome-related organelles complex 3 (BLOC-3): a complex containing the Hermansky-Pudlak syndrome (HPS) proteins HPS1 and HPS4. Proc Natl Acad Sci USA. 2003;100(15):8770\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2083_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev.genom.9.081307.164303","volume":"9","author":"M Huizing","year":"2008","unstructured":"Huizing M, Helip-Wooley A, Westbroek W, Gunay-Aygun M, Gahl WA. Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics. Annu Rev Genomics Hum Genet. 2008;9:359\u201386.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"17","key":"2083_CR3","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.1073\/pnas.94.17.8924","volume":"94","author":"RP Erickson","year":"1997","unstructured":"Erickson RP. Pigment, platelets, and Hermansky-Pudlak in human and mouse. Proc Natl Acad Sci USA. 1997;94(17):8924\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2083_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/9780470015902.a0024328.pub2","volume":"2017","author":"M Huizing","year":"2017","unstructured":"Huizing M, Gochuico BR, Gahl WA, et al. Molecular genetics of Hermansky-Pudlak syndrome. eLS. 2017;2017:1\u201310. https:\/\/doi.org\/10.1002\/9780470015902.a0024328.pub2.","journal-title":"eLS"},{"issue":"10","key":"2083_CR5","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/s41436-020-0867-5","volume":"22","author":"P Pennamen","year":"2020","unstructured":"Pennamen P, Le L, Tingaud-Sequeira A, Fiore M, Bauters A, Van Duong BN, et al. BLOC1S5 pathogenic variants cause a new type of Hermansky-Pudlak syndrome. Genet Med. 2020;22(10):1613\u201322.","journal-title":"Genet Med"},{"issue":"18","key":"2083_CR6","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1056\/NEJM199804303381803","volume":"338","author":"WA Gahl","year":"1998","unstructured":"Gahl WA, Brantly M, Kaiser-Kupfer MI, Iwata F, Hazelwood S, Shotelersuk V, et al. Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome). N Engl J Med. 1998;338(18):1258\u201364.","journal-title":"N Engl J Med"},{"issue":"1","key":"2083_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1378\/chest.117.1.129","volume":"117","author":"M Brantly","year":"2000","unstructured":"Brantly M, Avila NA, Shotelersuk V, Lucero C, Huizing M, Gahl WA. Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1. Chest. 2000;117(1):129\u201336.","journal-title":"Chest"},{"key":"2083_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2119\/molmed.2011.00198","volume":"18","author":"BR Gochuico","year":"2012","unstructured":"Gochuico BR, Huizing M, Golas GA, Scher CD, Tsokos M, Denver SD, et al. Interstitial lung disease and pulmonary fibrosis in Hermansky-Pudlak syndrome type 2, an adaptor protein-3 complex disease. Mol Med. 2012;18:56\u201364.","journal-title":"Mol Med"},{"issue":"10","key":"2083_CR9","first-page":"1839","volume":"13","author":"GW Vicary","year":"2016","unstructured":"Vicary GW, Vergne Y, Santiago-Cornier A, Young LR, Roman J. Pulmonary fibrosis in Hermansky-Pudlak syndrome. Ann Am Thorac Soc. 2016;13(10):1839\u201346.","journal-title":"Ann Am Thorac Soc"},{"key":"2083_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1183\/16000617.0193-2020","volume":"30","author":"T Yokoyama","year":"2021","unstructured":"Yokoyama T, Gochuico BR. Hermansky-Pudlak syndrome pulmonary fibrosis: a rare inherited interstitial lung disease. Eur Respir Rev. 2021;30:159.","journal-title":"Eur Respir Rev"},{"issue":"3","key":"2083_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1096-7192(02)00044-6","volume":"76","author":"WA Gahl","year":"2002","unstructured":"Gahl WA, Brantly M, Troendle J, Avila NA, Padua A, Montalvo C, et al. Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome. Mol Genet Metab. 2002;76(3):234\u201342.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"2083_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ymgme.2011.02.003","volume":"103","author":"K O'Brien","year":"2011","unstructured":"O\u2019Brien K, Troendle J, Gochuico BR, Markello TC, Salas J, Cardona H, et al. Pirfenidone for the treatment of Hermansky-Pudlak syndrome pulmonary fibrosis. Mol Genet Metab. 2011;103(2):128\u201334.","journal-title":"Mol Genet Metab"},{"issue":"10","key":"2083_CR13","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/j.healun.2004.11.015","volume":"24","author":"DJ Lederer","year":"2005","unstructured":"Lederer DJ, Kawut SM, Sonett JR, Vakiani E, Seward SL Jr, White JG, et al. Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky-Pudlak syndrome. J Heart Lung Transplant. 2005;24(10):1697\u20139.","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"2083_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194193","volume":"13","author":"S El-Chemaly","year":"2018","unstructured":"El-Chemaly S, O\u2019Brien KJ, Nathan SD, Weinhouse GL, Goldberg HJ, Connors JM, et al. Clinical management and outcomes of patients with Hermansky-Pudlak syndrome pulmonary fibrosis evaluated for lung transplantation. PLoS ONE. 2018;13(3): e0194193.","journal-title":"PLoS ONE"},{"issue":"22","key":"2083_CR15","doi-asserted-by":"publisher","first-page":"20332","DOI":"10.1074\/jbc.M300090200","volume":"278","author":"PW Chiang","year":"2003","unstructured":"Chiang PW, Oiso N, Gautam R, Suzuki T, Swank RT, Spritz RA. The Hermansky-Pudlak syndrome 1 (HPS1) and HPS4 proteins are components of two complexes, BLOC-3 and BLOC-4, involved in the biogenesis of lysosome-related organelles. J Biol Chem. 2003;278(22):20332\u20137.","journal-title":"J Biol Chem"},{"issue":"22","key":"2083_CR16","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.cub.2012.09.020","volume":"22","author":"A Gerondopoulos","year":"2012","unstructured":"Gerondopoulos A, Langemeyer L, Liang JR, Linford A, Barr FA. BLOC-3 mutated in Hermansky-Pudlak syndrome is a Rab32\/38 guanine nucleotide exchange factor. Curr Biol. 2012;22(22):2135\u20139.","journal-title":"Curr Biol"},{"issue":"8","key":"2083_CR17","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1172\/JCI79792","volume":"125","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, He CH, Herzog EL, Peng X, Lee CM, Nguyen TH, et al. Chitinase 3-like-1 and its receptors in Hermansky-Pudlak syndrome-associated lung disease. J Clin Investig. 2015;125(8):3178\u201392.","journal-title":"J Clin Investig"},{"issue":"18","key":"2083_CR18","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1073\/pnas.1702750114","volume":"114","author":"MJ Bollong","year":"2017","unstructured":"Bollong MJ, Yang B, Vergani N, Beyer BA, Chin EN, Zambaldo C, et al. Small molecule-mediated inhibition of myofibroblast transdifferentiation for the treatment of fibrosis. Proc Natl Acad Sci USA. 2017;114(18):4679\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"2083_CR19","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1073\/pnas.1621375114","volume":"114","author":"G Wernig","year":"2017","unstructured":"Wernig G, Chen SY, Cui L, Van Neste C, Tsai JM, Kambham N, et al. Unifying mechanism for different fibrotic diseases. Proc Natl Acad Sci USA. 2017;114(18):4757\u201362.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2083_CR20","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1165\/rcmb.2013-0025OC","volume":"50","author":"AR Cullinane","year":"2014","unstructured":"Cullinane AR, Yeager C, Dorward H, Carmona-Rivera C, Wu HP, Moss J, et al. Dysregulation of galectin-3. Implications for Hermansky-Pudlak syndrome pulmonary fibrosis. Am J Respir Cell Mol Biol. 2014;50(3):605\u201313.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"11\u201312","key":"2083_CR21","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.2119\/molmed.2010.00265","volume":"17","author":"JE Bond","year":"2011","unstructured":"Bond JE, Bergeron A, Thurlow P, Selim MA, Bowers EV, Kuang A, et al. Angiotensin-II mediates nonmuscle myosin II activation and expression and contributes to human keloid disease progression. Mol Med. 2011;17(11\u201312):1196\u2013203.","journal-title":"Mol Med"},{"issue":"2","key":"2083_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nprot.2007.30","volume":"2","author":"CC Liang","year":"2007","unstructured":"Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007;2(2):329\u201333.","journal-title":"Nat Protoc"},{"issue":"3","key":"2083_CR23","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1091\/mbc.e03-06-0359","volume":"15","author":"CM Lo","year":"2004","unstructured":"Lo CM, Buxton DB, Chua GC, Dembo M, Adelstein RS, Wang YL. Nonmuscle myosin IIb is involved in the guidance of fibroblast migration. Mol Biol Cell. 2004;15(3):982\u20139.","journal-title":"Mol Biol Cell"},{"issue":"5","key":"2083_CR24","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1074\/jbc.M607174200","volume":"282","author":"RD Bennett","year":"2007","unstructured":"Bennett RD, Mauer AS, Strehler EE. Calmodulin-like protein increases filopodia-dependent cell motility via up-regulation of myosin-10. J Biol Chem. 2007;282(5):3205\u201312.","journal-title":"J Biol Chem"},{"issue":"47","key":"2083_CR25","doi-asserted-by":"publisher","first-page":"35873","DOI":"10.1074\/jbc.M605343200","volume":"281","author":"JC Sandquist","year":"2006","unstructured":"Sandquist JC, Swenson KI, Demali KA, Burridge K, Means AR. Rho kinase differentially regulates phosphorylation of nonmuscle myosin II isoforms A and B during cell rounding and migration. J Biol Chem. 2006;281(47):35873\u201383.","journal-title":"J Biol Chem"},{"issue":"44","key":"2083_CR26","doi-asserted-by":"publisher","first-page":"17991","DOI":"10.1073\/pnas.1106499108","volume":"108","author":"JR Beach","year":"2011","unstructured":"Beach JR, Hussey GS, Miller TE, Chaudhury A, Patel P, Monslow J, et al. Myosin II isoform switching mediates invasiveness after TGF-beta-induced epithelial-mesenchymal transition. Proc Natl Acad Sci USA. 2011;108(44):17991\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2083_CR27","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.yexcr.2010.01.024","volume":"316","author":"V Betapudi","year":"2010","unstructured":"Betapudi V, Rai V, Beach JR, Egelhoff T. Novel regulation and dynamics of myosin II activation during epidermal wound responses. Exp Cell Res. 2010;316(6):980\u201391.","journal-title":"Exp Cell Res"},{"issue":"4","key":"2083_CR28","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/HJH.0000000000000083","volume":"32","author":"S Yang","year":"2014","unstructured":"Yang S, Zhong Q, Qiu Z, Chen X, Chen F, Mustafa K, et al. Angiotensin II receptor type 1 autoantibodies promote endothelial microparticles formation through activating p38 MAPK pathway. J Hypertens. 2014;32(4):762\u201370.","journal-title":"J Hypertens"},{"issue":"11","key":"2083_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078695","volume":"8","author":"KKV Haack","year":"2013","unstructured":"Haack KKV, Mitra AK, Zucker IH. NF-\u03baB and CREB are required for angiotensin II type 1 receptor upregulation in neurons. PLoS ONE. 2013;8(11): e78695.","journal-title":"PLoS ONE"},{"issue":"5","key":"2083_CR30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1161\/01.HYP.15.5.459","volume":"15","author":"PC Wong","year":"1990","unstructured":"Wong PC, Price WA Jr, Chiu AT, Duncia JV, Carini DJ, Wexler RR, et al. Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X. Hypertension. 1990;15(5):459\u201368.","journal-title":"Hypertension"},{"issue":"34","key":"2083_CR31","doi-asserted-by":"publisher","first-page":"31720","DOI":"10.1074\/jbc.M104036200","volume":"276","author":"WH Faour","year":"2001","unstructured":"Faour WH, He Y, He QW, de Ladurantaye M, Quintero M, Mancini A, et al. Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts. J Biol Chem. 2001;276(34):31720\u201331.","journal-title":"J Biol Chem"},{"issue":"8","key":"2083_CR32","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2165\/00003088-200544080-00003","volume":"44","author":"DA Sica","year":"2005","unstructured":"Sica DA, Gehr TW, Ghosh S. Clinical pharmacokinetics of losartan. Clin Pharmacokinet. 2005;44(8):797\u2013814.","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"2083_CR33","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1073\/pnas.1018892108","volume":"108","author":"B Diop-Frimpong","year":"2011","unstructured":"Diop-Frimpong B, Chauhan VP, Krane S, Boucher Y, Jain RK. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors. Proc Natl Acad Sci USA. 2011;108(7):2909\u201314.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2083_CR34","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000090140","volume":"73","author":"HW Yao","year":"2006","unstructured":"Yao HW, Zhu JP, Zhao MH, Lu Y. Losartan attenuates bleomycin-induced pulmonary fibrosis in rats. Respiration. 2006;73(2):236\u201342.","journal-title":"Respiration"},{"issue":"5","key":"2083_CR35","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1177\/0960327114543840","volume":"34","author":"F Guo","year":"2015","unstructured":"Guo F, Sun YB, Su L, Li S, Liu ZF, Li J, et al. Losartan attenuates paraquat-induced pulmonary fibrosis in rats. Hum Exp Toxicol. 2015;34(5):497\u2013505.","journal-title":"Hum Exp Toxicol"},{"issue":"5","key":"2083_CR36","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00408-012-9410-z","volume":"190","author":"M Couluris","year":"2012","unstructured":"Couluris M, Kinder BW, Xu P, Gross-King M, Krischer J, Panos RJ. Treatment of idiopathic pulmonary fibrosis with losartan: a pilot project. Lung. 2012;190(5):523\u20137.","journal-title":"Lung"},{"issue":"2","key":"2083_CR37","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3748\/wjg.v12.i2.322","volume":"12","author":"S Yokohama","year":"2006","unstructured":"Yokohama S, Tokusashi Y, Nakamura K, Tamaki Y, Okamoto S, Okada M, et al. Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis. World J Gastroenterol. 2006;12(2):322\u20136.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"2083_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1083\/jcb.201605090","volume":"214","author":"MK Dennis","year":"2016","unstructured":"Dennis MK, Delevoye C, Acosta-Ruiz A, Hurbain I, Romao M, Hesketh GG, et al. BLOC-1 and BLOC-3 regulate VAMP7 cycling to and from melanosomes via distinct tubular transport carriers. J Cell Biol. 2016;214(3):293\u2013308.","journal-title":"J Cell Biol"},{"issue":"17","key":"2083_CR39","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.88947","volume":"1","author":"LR Young","year":"2016","unstructured":"Young LR, Gulleman PM, Short CW, Tanjore H, Sherrill T, Qi A, et al. Epithelial-macrophage interactions determine pulmonary fibrosis susceptibility in Hermansky-Pudlak syndrome. JCI insight. 2016;1(17): e88947.","journal-title":"JCI insight"},{"issue":"1","key":"2083_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nm1685","volume":"14","author":"AM Tager","year":"2008","unstructured":"Tager AM, LaCamera P, Shea BS, Campanella GS, Selman M, Zhao Z, et al. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med. 2008;14(1):45\u201354.","journal-title":"Nat Med"},{"key":"2083_CR41","doi-asserted-by":"publisher","first-page":"W130","DOI":"10.1093\/nar\/gkh366","volume":"32","author":"B Yuan","year":"2004","unstructured":"Yuan B, Latek R, Hossbach M, Tuschl T, Lewitter F. siRNA Selection Server: an automated siRNA oligonucleotide prediction server. Nucleic Acids Res. 2004;32:W130\u20134.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2083_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1006\/dbio.2002.0711","volume":"248","author":"ND Lawson","year":"2002","unstructured":"Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol. 2002;248(2):307\u201318.","journal-title":"Dev Biol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02083-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02083-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02083-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T14:10:27Z","timestamp":1655993427000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02083-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2083"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02083-w","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"assertion":[{"value":"17 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The acquisition of lung fibroblasts from subjects with HPS-1 was approved by the Institutional Review Board (IRB) of the National Human Genome Research Institute (Protocol 04-HG-0211). Subjects provided written informed consent to participate in these studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"167"}}